Perioperative blood transfusions in orthopaedic surgery

Journal of Bone and Joint Surgery - American Volume

Volumn 96, Issue 21, 2014, Pages 1836-1844

  Ponnusamy, Karthikeyan E ^a   Kim, Thomas J ^a   Khanuja, Harpal S ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGIC REACTION; ANEMIA; BLOOD COMPONENT; BLOOD STORAGE; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; BLOODBORNE BACTERIUM; BLOODSTREAM INFECTION; CARDIOVASCULAR DISEASE; CLINICAL STUDY; ERYTHROCYTE TRANSFUSION; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOMODULATION; LUNG EDEMA; ORTHOPEDIC SURGERY; PERIOPERATIVE PERIOD; PLASMA TRANSFUSION; POSTOPERATIVE COMPLICATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SURGICAL INFECTION; SYSTEMATIC REVIEW (TOPIC); TRANSFUSION ASSOCIATED CIRCULATORY OVERLOAD; TRANSFUSION RELATED ACUTE LUNG INJURY; VENOUS THROMBOEMBOLISM; ACUTE LUNG INJURY; ADULT; GENETICS; GRAFT VS HOST DISEASE; HYPERSENSITIVITY; PHYSIOLOGY; SHOCK;

ACUTE LUNG INJURY; ADULT; BLOOD TRANSFUSION; BLOOD-BORNE PATHOGENS; GRAFT VS HOST DISEASE; HUMANS; HYPERSENSITIVITY; IMMUNOMODULATION; ORTHOPEDIC PROCEDURES; PERIOPERATIVE PERIOD; SHOCK; VENOUS THROMBOEMBOLISM;

EID: 84910614264     PISSN: 00219355     EISSN: 15351386     Source Type: Journal    
DOI: 10.2106/JBJS.N.00128     Document Type: Review

References (78)

1. Goodnough LT, Levy JH, Murphy MF. Concepts of blood transfusion in adults. Lancet. 2013 May 25;381(9880):1845-54.
2. Young SW, Marsh DJ, Akhavani MA, Walker CG, Skinner JA. Attitudes to blood transfusion post arthroplasty surgery in the United Kingdom: a national survey. Int Orthop. 2008 Jun;32(3):325-9. Epub 2007 Mar 30.
3. Banerjee S, Issa K, Kapadia BH, Khanuja HS, Harwin SF, McInerney VK, Mont MA. Intraoperative nonpharmacotherapeutic blood management strategies in total knee arthroplasty. J Knee Surg. 2013 Dec;26(6):387-93. Epub 2013 Aug 19.
4. Cherian JJ, Banerjee S, Kapadia BH, Sodhi GS, Issa K, Harwin SF, Mont MA. Nonsurgical intra-operative blood management strategies for total hip arthroplasty. Surg Technol Int. 2014 Mar;24:326-32.
5. Cherian JJ, Kapadia BH, Banerjee S, Jauregui JJ, Issa K, Harwin SF, Mont MA. Surgical intra-operative blood management strategies for total hip arthroplasty. Surg Technol Int. 2013 Dec 17;XXIII:319-25. Epub ahead of print.
6. Cherian JJ, Kapadia BH, Issa K, Banerjee S, McInerney VK, Harwin SF, Mont MA. Preoperative blood management strategies for total hip arthroplasty. Surg Technol Int. 2013 Sep;23:261-6.
7. Jauregui JJ, Issa K, Kapadia BH, Banerjee S, Harwin SF, Mont MA. Post-operative blood management strategies for total hip arthroplasty. Surg Technol Int. 2014 Mar;24:333-7.
8. Whitaker BI, Green J, King MR, Leibeg LL, Mathew SM, Schlumpf KS, Schreiber GB. The 2007 National Blood Collection and Utilization Survey Report. http://www.hhs.gov/ash/bloodsafety/2007nbcus-survey.pdf. Accessed 2014 Jan 6.
9. Serious Hazards of Transfusion. SHOT annual report and summaries. http://www.shotuk.org/shot-reports/. Accessed 2014 Jan 29.
10. U.S. Food and Drug Administration. Vaccines, blood & biologics. Available at: http://www.fda.gov/BiologicsBloodVaccines/default.htm. Accessed January 29. 2014.
11. Alam A, Lin Y, Lima A, Hansen M, Callum JL. The prevention of transfusion-associated circulatory overload. Transfus Med Rev. 2013 Apr;27(2):105-12. Epub 2013 Mar 1.
12. Hirayama F. Current understanding of allergic transfusion reactions: incidence, pathogenesis, laboratory tests, prevention and treatment. Br J Haematol. 2013 Feb;160(4):434-44. Epub 2012 Dec 6.
13. Jawa RS, Young DH, Stothert JC, Kulaylat MN, Landmark JD. Transfusion-associated graft versus host disease in the immunocompetent patient: an ongoing problem. J Intensive Care Med. 2013 Jun 20. Epub ahead of print.
14. Lieberman L, Maskens C, Cserti-Gazdewich C, Hansen M, Lin Y, Pendergrast J, Yi QL, Callum J. A retrospective review of patient factors, transfusion practices, and outcomes in patients with transfusion-associated circulatory overload. Transfus Med Rev. 2013 Oct;27(4):206-12. Epub 2013 Sep 26.
15. Menis M, Anderson SA, Forshee RA, McKean S, Johnson C, Holness L, Warnock R, Gondalia R, Worrall CM, Kelman JA, Ball R, Izurieta HS. Transfusion-associated circulatory overload (TACO) and potential risk factors among the inpatient US elderly as recorded in Medicare administrative databases during 2011. Vox Sang. 2014 Feb;106(2):144-52. Epub 2013 Jul 12.
16. U.S. Food and Drug Administration. Fatalities reported to FDA following blood collection and transfusion: annual summary for fiscal year 2012. http://www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/ReportaProblem/TransfusionDonationFatalities/ucm346639.htm. Accessed 2014 Jan 6.
17. Vamvakas EC. Possible mechanisms of allogeneic blood transfusion-associated postoperative infection. Transfus Med Rev. 2002 Apr;16(2):144-60.
18. Vlaar AP, Juffermans NP. Transfusion-related acute lung injury: a clinical review. Lancet. 2013 Sep 14;382(9896):984-94. Epub 2013 May 01.
19. Kennedy LD, Case LD, Hurd DD, Cruz JM, Pomper GJ. A prospective, randomized, double-blind controlled trial of acetaminophen and diphenhydramine pre-transfusion medication versus placebo for the prevention of transfusion reactions. Transfusion. 2008 Nov;48(11):2285-91. Epub 2008 Jul 30.
20. Palfi M, Berg S, Ernerudh J, Berlin G. A randomized controlled trial of transfusion-related acute lung injury: is plasma from multiparous blood donors dangerous? Transfusion. 2001 Mar;41(3):317-22.
21. Triulzi DJ, Kleinman S, Kakaiya RM, Busch MP, Norris PJ, Steele WR, Glynn SA, Hillyer CD, Carey P, Gottschall JL, Murphy EL, Rios JA, Ness PM, Wright DJ, Carrick D, Schreiber GB. The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion-related acute lung injury risk reduction strategy. Transfusion. 2009 Sep;49(9):1825-35. Epub 2009 May 18.
22. Nakazawa H, Ohnishi H, Okazaki H, Hashimoto S, Hotta H, Watanabe T, Ohkawa R, Yatomi Y, Nakajima K, Iwao Y, Takamoto S, Shimizu M, Iijima T. Impact of fresh-frozen plasma from male-only donors versus mixed-sex donors on postoperative respiratory function in surgical patients: a prospective case-controlled study. Transfusion. 2009 Nov;49(11):2434-41. Epub 2009 Jul 16.
23. Toy P, Gajic O, Bacchetti P, Looney MR, Gropper MA, Hubmayr R, Lowell CA, Norris PJ, Murphy EL, Weiskopf RB, Wilson G, Koenigsberg M, Lee D, Schuller R, Wu P, Grimes B, Gandhi MJ, Winters JL, Mair D, Hirschler N, Sanchez Rosen R, Matthay MA; TRALI Study Group. Transfusion-related acute lung injury: incidence and risk factors. Blood. 2012 Feb 16;119(7):1757-67. Epub 2011 Nov 23. http:/dx.doi.org/10.2106/JBJS.N.00128
24. NIH Blood Bank. AB plasma donor program. http://www.cc.nih.gov/blooddonor/donationtypes/ab-plasma.html. Accessed 2014 Jan 29.
25. Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, Tweeddale M, Schweitzer I, Yetisir E, Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med. 1999 Feb 11;340(6):409-17.
26. Public Health Agency of Canada. Transfusion transmitted injuries surveillance system. Available at http://www.transfusionmedicine.ca/sites/transfusionmedicine/files/PDF/TTISS-Users%20Manual%203.0.pdf. Accessed 2014 Jan 29.
27. Nilsson KR, Berenholtz SM, Garrett-Mayer E, Dorman T, Klag MJ, Pronovost PJ. Association between venous thromboembolism and perioperative allogeneic transfusion. Arch Surg. 2007 Feb;142(2):126-32 discussion 133.
28. Xenos ES, Vargas HD, Davenport DL. Association of blood transfusion and venous thromboembolism after colorectal cancer resection. Thromb Res. 2012 May;129(5):568-72. Epub 2011 Aug 27.
29. Anders MJ, Lifeso RM, Landis M, Mikulsky J, Meinking C, McCracken KS. Effect of preoperative donation of autologous blood on deep-vein thrombosis following total joint arthroplasty of the hip or knee. J Bone Joint Surg Am. 1996 Apr;78(4): 574-80.
30. Bae H, Westrich GH, Sculco TP, Salvati EA, Reich LM. The effect of preoperative donation of autologous blood on deep-vein thrombosis after total hip arthroplasty. J Bone Joint Surg Br. 2001 Jul;83(5):676-9.
31. U.S. Food and Drug Administration. Keeping blood transfusions safe: FDA's multi-layered protections for donated blood. http://www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/BloodSafety/ucm095522.htm. Accessed 2014 Jan 6.
32. Fournier-Wirth C, Jaffrezic-Renault N, Coste J. Detection of blood-transmissible agents: can screening be miniaturized? Transfusion. 2010 Sep;50(9):2032-45.
33. Schwarzkopf R, Chung C, Park JJ, Walsh M, Spivak JM, Steiger D. Effects of perioperative blood product use on surgical site infection following thoracic and lumbar spinal surgery. Spine (Phila Pa 1976). 2010 Feb 1;35(3):340-6.
34. García-Alvarez F, Al-Ghanem R, García-Alvarez I, López-Baisson A, Bernal M. Risk factors for postoperative infections in patients with hip fracture treated by means of Thompson arthroplasty. Arch Gerontol Geriatr. 2010 Jan-Feb;50(1):51-5. Epub 2009 Feb 23.
35. Ho C, Sucato DJ, Richards BS. Risk factors for the development of delayed infections following posterior spinal fusion and instrumentation in adolescent idiopathic scoliosis patients. Spine (Phila Pa 1976). 2007 Sep 15;32(20): 2272-7.
36. Morris CD, Sepkowitz K, Fonshell C, Margetson N, Eagan J, Miransky J, Boland PJ, Healey J. Prospective identification of risk factors for wound infection after lower extremity oncologic surgery. Ann Surg Oncol. 2003 Aug;10(7):778-82.
37. Thanni LOA, Aigoro NO. Surgical site infection complicating internal fixation of fractures: incidence and risk factors. J Natl Med Assoc. 2004 Aug;96(8):1070-2.
38. Woods BI, Rosario BL, Chen A, Waters JH, Donaldson W 3rd, Kang J, Lee J. The association between perioperative allogeneic transfusion volume and postoperative infection in patients following lumbar spine surgery. J Bone Joint Surg Am. 2013 Dec 4;95(23):2105-10.
39. Newman ET, Watters TS, Lewis JS, Jennings JM, Wellman SS, Attarian DE, Grant SA, Green CL, Vail TP, Bolognesi MP. Impact of perioperative allogeneic and autologous blood transfusion on acute wound infection following total knee and total hip arthroplasty. J Bone Joint Surg Am. 2014 Feb 19;96(4):279-84.
40. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR; Hospital Infection Control Practices Advisory Committee. Guideline for prevention of surgical site infection, 1999. Infect Control Hosp Epidemiol. 1999 Apr;20(4):250-78; quiz 279-80.
41. Steinitz D, Harvey EJ, Leighton RK, Petrie DP. Is homologous blood transfusion a risk factor for infection after hip replacement? Can J Surg. 2001 Oct;44(5):355-8.
42. Basora M, Pereira A, Soriano A, Martínez-Pastor JC, Sánchez-Etayo G, Tió M, Salazar F. Allogeneic blood transfusion does not increase the risk of wound infection in total knee arthroplasty. Vox Sang. 2010 Feb;98(2):124-9. Epub 2009 Sep 14.
43. Drosos GI, Blatsoukas KS, Ververidis A, Tripsianis G, Chloropoulou P, Iatrou C, Kazakos K, Verettas DA. Blood transfusion and cytokines' changes in total knee replacement. Arch Orthop Trauma Surg. 2012 Oct;132(10):1505-13. Epub 2012 Jun 21.
44. Friedman R, Homering M, Holberg G, Berkowitz SD. Allogeneic blood transfusions and postoperative infections after total hip or knee arthroplasty. J Bone Joint Surg Am. 2014 Feb 19;96(4):272-8.
45. Innerhofer P, Klingler A, Klimmer C, Fries D, Nussbaumer W. Risk for postoperative infection after transfusion of white blood cell-filtered allogeneic or autologous blood components in orthopedic patients undergoing primary arthroplasty. Transfusion. 2005 Jan;45(1):103-10.
46. Innerhofer P, Walleczek C, Luz G, Hobisch-Hagen P, Benzer A, Stöckl B, Hessenberger G, Nussbaumer W, Schobersberger W. Transfusion of buffy coat-depleted blood components and risk of postoperative infection in orthopedic patients. Transfusion. 1999 Jun;39(6):625-32.
47. Levi N, Sandberg T. Blood transfusion and postoperative wound infection in intracapsular femoral neck fractures. Bull Hosp Jt Dis. 1998;57(2):69-73.
48. Llewelyn CA, Taylor RS, Todd AAM, Stevens W, Murphy MF, Williamson LM; Leucodepletion Study Group. The effect of universal leukoreduction on postoperative infections and length of hospital stay in elective orthopedic and cardiac surgery. Transfusion. 2004 Apr;44(4):489-500.
49. Shander A, Spence RK, Adams D, Shore-Lesserson L, Walawander CA. Timing and incidence of postoperative infections associated with blood transfusion: analysis of 1,489 orthopedic and cardiac surgery patients. Surg Infect (Larchmt). 2009 Jun;10(3):277-83.
50. Slappendel R, Dirksen R, Weber EWG, van der Schaaf DB. An algorithm to reduce allogenic red blood cell transfusions for major orthopedic surgery. Acta Orthop Scand. 2003 Oct;74(5):569-75.
51. Aguilera X, Martinez-Zapata MJ, Bosch A, Urrútia G, Gonzalez JC, Jordan M, Gich I, Maymó RM, Martínez N, Monllau JC, Celaya F, Fernandez JA. Efficacy and safety of fibrin glue and tranexamic acid to prevent postoperative blood loss in total knee arthroplasty: a randomized controlled clinical trial. J Bone Joint Surg Am. 2013 Nov 20;95(22):2001-7.
52. Chimento GF, Huff T, Ochsner JL Jr, Meyer M, Brandner L, Babin S. An evaluation of the use of topical tranexamic acid in total knee arthroplasty. J Arthroplasty. 2013 Sep;28(8)(Suppl):74-7.
53. Gilbody J, Dhotar HS, Perruccio AV, Davey JR. Topical tranexamic acid reduces transfusion rates in total hip and knee arthroplasty. J Arthroplasty. 2014 Apr; 29(4):681-4. Epub 2013 Oct 4.
54. Martin JG, Cassatt KB, Kincaid-Cinnamon KA, Westendorf DS, Garton AS, Lemke JH. Topical administration of tranexamic acid in primary total hip and total knee arthroplasty. J Arthroplasty. 2014 May;29(5):889-94. Epub 2013 Oct 16.
55. Thoms RJ, Marwin SE. The role of fibrin sealants in orthopaedic surgery. J Am Acad Orthop Surg. 2009 Dec;17(12):727-36.
56. Yang B, Li H, Wang D, He X, Zhang C, Yang P. Systematic review and metaanalysis of perioperative intravenous tranexamic acid use in spinal surgery. PLoS One. 2013;8(2):e55436. Epub 2013 Feb 12.
57. Alsaleh K, Alotaibi GS, Almodaimegh HS, Aleem AA, Kouroukis CT. The use of preoperative erythropoiesis-stimulating agents (ESAs) in patients who underwent knee or hip arthroplasty: a meta-analysis of randomized clinical trials. J Arthroplasty. 2013 Oct;28(9):1463-72. Epub 2013 Mar 23.
58. Cobain TJ, Vamvakas EC, Wells A, Titlestad K. A survey of the demographics of blood use. Transfus Med. 2007 Feb;17(1):1-15.
59. Boralessa H, Goldhill DR, Tucker K, Mortimer AJ, Grant-Casey J. National comparative audit of blood use in elective primary unilateral total hip replacement surgery in the UK. Ann R Coll Surg Engl. 2009 Oct;91(7):599-605. Epub 2009 Aug 14.
60. Chen AF, Klatt BA, Yazer MH, Waters JH. Blood utilization after primary total joint arthroplasty in a large hospital network. HSS J. 2013 Jul;9(2):123-8. Epub 2013 Jun 21.
61. Hutton B, Fergusson D, Tinmouth A, McIntyre L, Kmetic A, Hébert PC. Transfusion rates vary significantly amongst Canadian medical centres. Can J Anaesth. 2005 Jun-Jul;52(6):581-90.
62. Shehata N, Wilson K, Mazer CD, Tomlinson G, Streiner D, Hébert P, Naglie G. The proportion of variation in perioperative transfusion decisions in Canada attributable to the hospital. Can J Anaesth. 2007 Nov;54(11):902-7.
63. Qian F, Osler TM, Eaton MP, Dick AW, Hohmann SF, Lustik SJ, Diachun CA, Pasternak R, Wissler RN, Glance LG. Variation of blood transfusion in patients undergoing major noncardiac surgery. Ann Surg. 2013 Feb;257(2):266-78.
64. Browne JA, Adib F, Brown TE, Novicoff WM. Transfusion rates are increasing following total hip arthroplasty: risk factors and outcomes. J Arthroplasty. 2013 Sep;28(8)(Suppl):34-7. Epub 2013 Jul 26.
65. Barr PJ, Donnelly M, Cardwell C, Alam SS, Morris K, Parker M, Bailie KEM. Drivers of transfusion decision making and quality of the evidence in orthopedic surgery: a systematic review of the literature. Transfus Med Rev. 2011 Oct; 25(4):304-16.e1: 6. Epub 2011 Jun 2.
66. Carson JL, Noveck H, Berlin JA, Gould SA. Mortality and morbidity in patients with very low postoperative Hb levels who decline blood transfusion. Transfusion. 2002 Jul;42(7):812-8.
67. Spence RK, Costabile JP, Young GS, Norcross ED, Alexander JB, Pello MJ, Atabek UM, Camishion RC. Is hemoglobin level alone a reliable predictor of outcome in the severely anemic surgical patient? Am Surg. 1992 Feb;58(2):92-5.
68. Hajjar LA, Vincent JL, Galas FRBG, Nakamura RE, Silva CMP, Santos MH, Fukushima J, Kalil Filho R, Sierra DB, Lopes NH, Mauad T, Roquim AC, Sundin MR, Leão WC, Almeida JP, Pomerantzeff PM, Dallan LO, Jatene FB, Stolf NAG, Auler JOC Jr. Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial. JAMA. 2010 Oct 13;304(14):1559-67.
69. Villanueva C, Colomo A, Bosch A, Concepción M, Hernandez-Gea V, Aracil C, Graupera I, Poca M, Alvarez-Urturi C, Gordillo J, Guarner-Argente C, Santaló M, Muñiz E, Guarner C. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med. 2013 Jan 3;368(1):11-21.
70. Carson JL, Carless PA, Hebert PC. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev. 2012;4:CD002042. Epub 2012 Apr 18.
71. Carson JL, Terrin ML, Barton FB, Aaron R, Greenburg AG, Heck DA, Magaziner J, Merlino FE, Bunce G, McClelland B, Duff A, Noveck H. A pilot randomized trial comparing symptomatic vs. hemoglobin-level-driven red blood cell transfusions following hip fracture. Transfusion. 1998 Jun;38(6):522-9.
72. Carson JL, Terrin ML, Noveck H, Sanders DW, Chaitman BR, Rhoads GG, Nemo G, Dragert K, Beaupre L, Hildebrand K, Macaulay W, Lewis C, Cook DR, Dobbin G, Zakriya KJ, Apple FS, Horney RA, Magaziner J; FOCUS Investigators. Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med. 2011 Dec 29;365(26):2453-62. Epub 2011 Dec 14.
73. Foss NB, Kristensen MT, Jensen PS, Palm H, Krasheninnikoff M, Kehlet H. The effects of liberal versus restrictive transfusion thresholds on ambulation after hip fracture surgery. Transfusion. 2009 Feb;49(2):227-34.
74. Grover M, Talwalkar S, Casbard A, Boralessa H, Contreras M, Boralessa H, Brett S, Goldhill DR, Soni N. Silent myocardial ischaemia and haemoglobin concentration: a randomized controlled trial of transfusion strategy in lower limb arthroplasty. Vox Sang. 2006 Feb;90(2):105-12.
75. Naylor JM, Adie S, Fransen M, Dietsch S, Harris I. Endorsing single-unit transfusion combined with a restrictive haemoglobin transfusion threshold after knee arthroplasty. Qual Saf Health Care. 2010 Jun;19(3):239-43. Epub 2010 Apr 21.
76. So-Osman C, Nelissen R, Brand R, Faber F, Slaa RT, Stiggelbout A, Brand A. The impact of a restrictive transfusion trigger on post-operative complication rate and well-being following elective orthopaedic surgery: a post-hoc analysis of a randomised study. Blood Transfus. 2013 Apr;11(2):289-95. Epub 2013 Feb 6.
77. So-Osman C, Nelissen R, Te Slaa R, Coene L, Brand R, Brand A. A randomized comparison of transfusion triggers in elective orthopaedic surgery using leucocyte-depleted red blood cells. Vox Sang. 2010 Jan;98(1):56-64. Epub 2009 Jul 23.
78. Wright JG, Einhorn TA, Heckman JD. Grades of recommendation. J Bone Joint Surg Am. 2005 Sep;87(9):1909-10.